Investment Pitches

Pitch Summary:
Consorcio Ara (Mexico: ARA) jumped 30% in Q1 on the back of strong Q4 results, which were followed by great first quarter earnings that were reported in April. We believe that the next generation leadership is driving substantial changes in the company. Revenue is now growing at more than 20% and cash flow by over 30%, yet the stock trades at 5 times trailing earnings and 32% of book value. While we wait for this transformation to continue from a low return on equity business that was a value trap into a growth story and a big improvement in return on equity, we get paid a dividend. We continue to be very bullish on Ara, and it is now our second largest position in the fund.

BSD Analysis:
The manager presents a compelling turnaround story for Consorcio Ara, highlighting new leadership driving operational improvements. The company has achieved impressive growth metrics with revenue expanding over 20% and cash flow growing by more than 30%. Despite this strong operational performance, the stock appears deeply undervalued at just 5x trailing earnings and 32% of book value. The manager views this as a transformation from a value trap into a genuine growth opportunity with improving return on equity. The dividend provides downside protection while waiting for the turnaround to fully materialize. The position sizing as the second largest holding demonstrates high conviction in the thesis.

Pitch Summary:
Grown Rogue recently announced its full year 2025 results, now fully consolidating New Jersey operations, and also provided forward-looking guidance for the first time, as it also transitioned from IFRS to U.S. GAAP accounting standards. The company posted solid headline growth with annual revenue increasing 22% and adjusted EBITDA up 43%, but more importantly in our view, the company's press release contains ample disclosure to underwrite the sustained growth rates they guided to. The core of our investment thesis is that Grown Rogue is a true small cap growth platform and it is refreshing to see a company paint a fundamentally-driven quantifiable growth picture. We think comparing Grown Rogue across the publicly-traded landscape of cannabis companies is comparing apples and oranges. In our last Bengal Bite, we wrote about the importance of Grown Rogue's New Jersey expansion to our growth thesis about the company, and these earnings results bore that out. The annual growth cited above came despite price normalization-driven revenue declines of 8% and 22% in Oregon and Michigan, respectively, with New Jersey more than making up the difference with $11.3 million in sales in its first full year of operations. Grown Rogue confirmed that it has begun construction on its Phase II expansion to incrementally double capacity in New Jersey, with an initial harvest expected in May from the first of four additional rooms anticipated to come online over the course of 2026. Grown Rogue's expansion from Oregon to Michigan showed that its model can travel. New Jersey added a few more data points: (1) Grown Rogue can find shelf space in large MSO stores; and (2) Grown Rogue can be trusted to deploy a larger amount of capital than they had before (>$10 million) while generating significant returns and what looks to be an <3 year payback period; (3) Grown Rogue has a significant opportunity to continue to push more sales into its branded products, increasing ASPs even potentially in Oregon and Michigan. Our main concern with Grown Rogue's mature markets, like Oregon and Michigan, is that they continue to generate cash even as prices normalize - and this is still what is happening. We expect cashflows to bounce around and be somewhat cyclical, so we are not overly concerned with percentage changes so long as we are confident that these operations continue to be cash flowing on a four wall basis. This year, the company has two new markets coming online: Minnesota and Illinois. Having shown the model can travel, Grown Rogue must now show that they can do two major projects at once. Simply put: a growth company that can open one really profitable operation per year is worth much less than a growth company that can open two. New Jersey's startup was fast by cannabis standards but still slipped a bit from Grown Rogue's initial estimates - Minnesota and Illinois give Grown Rogue the chance to show they can grow more quickly than before. And, demonstrating that should hopefully undergird investors' increased trust in Grown Rogue's future growth projections. That's a 56% increase in capacity happening this year with a lot more waiting to be brought online as market conditions allow. Furthermore, the geographic mix of this new capacity should materially increase Grown Rogue's blended average selling price. But ultimately, we don't own Grown Rogue because they have the most capacity or operate in the markets with the best pricing; we own them because they are laser-focused on growing high-quality weed as efficiently as humanly possible and have been delivering against that priority. Despite the revenue contraction mentioned above in the company's legacy markets of Oregon and Michigan, Grown Rogue managed ~15% increases in flower yield and ~12% decreases in flower COGS per pound in both markets. Grown Rogue's long-term guidance is 25% revenue growth and 35% adjusted EBITDA growth per year. Continuing to execute this year in Minnesota and Illinois will put powerful proof to these numbers.

BSD Analysis:
Bengal Capital presents a compelling bull case for Grown Rogue as a small-cap cannabis growth platform with proven execution capabilities. The company delivered strong 2025 results with 22% revenue growth and 43% adjusted EBITDA growth, driven primarily by successful New Jersey expansion that generated $11.3 million in first-year sales despite headwinds in mature Oregon and Michigan markets. The investment thesis centers on Grown Rogue's ability to replicate its cultivation model across multiple states while maintaining operational efficiency, evidenced by 15% yield improvements and 12% COGS reductions even amid price normalization. The company's aggressive expansion pipeline includes 56% capacity increases in 2026 across Minnesota and Illinois, with total nameplate capacity reaching 89,302 square feet versus current 37,302 square feet online. Management's guidance of 25% annual revenue growth and 35% adjusted EBITDA growth appears achievable given the geographic diversification strategy and focus on premium branded products. The key execution risk lies in simultaneously managing multiple market entries while maintaining the operational discipline that has driven success in existing markets.

Pitch Summary:
We like companies that repurchase shares when their stock trades below intrinsic value. Done correctly, buybacks increase per-share value and create a quiet, powerful tailwind for long-term owners. General Motors (GM) is a good example. While investors have often focused on cyclical concerns around autos, EV uncertainty, and broader macro risks, GM has continued to generate substantial free cash flow and has used that cash flow to aggressively reduce its share count at what we believe are attractive valuations. When a company buys back stock below intrinsic value, remaining shareholders own a larger percentage of the business without having to invest an additional dollar. That is not financial engineering. That is disciplined capital allocation.

BSD Analysis:
Ashva Capital presents a compelling value thesis on General Motors centered on disciplined capital allocation and attractive valuation. The manager argues that while the market fixates on cyclical auto concerns, EV transition uncertainty, and macro headwinds, GM continues generating substantial free cash flow and deploying it intelligently through share repurchases at discounted valuations. This creates a mathematical advantage for remaining shareholders who gain increased ownership without additional investment. The pitch emphasizes GM's ability to compound value through buybacks below intrinsic value, positioning the automaker as a beneficiary of market pessimism. The manager distinguishes between legitimate financial engineering and disciplined capital allocation, suggesting GM represents the latter. This contrarian approach capitalizes on investor myopia regarding traditional automakers while the business fundamentals remain sound.

Pitch Summary:
Palantir Technologies Inc. has demonstrated strong financial performance with significant revenue growth and profitability. Despite its high valuation, the company's unique position in the market and its strong ties to the U.S. defense sector provide a scarcity premium that is likely to persist. The company's financial health, with no debt and substantial liquidity, supports its premium valuation. The market's psychological factors and the company's mythological roots contribute to its high valuation, similar to Tesla. Palantir's non-cyclical nature and elite management team make it a long-term compounder, with a projected EPS of $2.50 by May 2028 and a target price of $200.

BSD Analysis:
Palantir's robust growth in U.S. commercial and government revenues underscores its strategic importance and market penetration. The company's high adjusted operating and free cash flow margins reflect operational efficiency and financial strength. Concerns about competition from companies like OpenAI and Google are mitigated by Palantir's focus on governance, security, and permissions, which are critical for high-security workflows. The company's integration into the broader software sector and ETF market dynamics further insulate it from significant valuation erosion. Palantir's forward PEG ratio, while above the sector average, is justified by its growth prospects and market position.

Pitch Summary:
Liberty Global's stock has slightly decreased from $12.50 to $12, despite the European telecom sector's significant growth. The company's telco assets are showing positive momentum, particularly with the Ziggo Group spin-off, which is expected to de-risk by the second half of 2027. Management has aligned their valuation with a $27 base case scenario. The spin-off catalyst is the primary reason for investment, as it presents a significant opportunity for value realization.

BSD Analysis:
The recent EU merger guidelines support market consolidation, which is crucial for innovation and infrastructure investments. Liberty Global's strategic moves, such as the sale of 50% of VodafoneZiggo and network sharing agreements, are progressing well, enhancing the spin-off's feasibility. The company's focus on reducing CapEx and achieving a EUR 500M free cash flow target by 2028 for Ziggo Group demonstrates a clear path to growth. However, risks remain, including potential European recession impacts and regulatory delays. Hedging against sector risks through shorting related ETFs could mitigate some exposure.

Pitch Summary:
AT&T Inc. is pivoting towards a high-margin, fiber-first business model, decoupling from its legacy burdens. The company's aggressive expansion into advanced connectivity, specifically fiber and 5G convergence, is expected to drive superior earnings growth and total shareholder returns. AT&T's recent earnings report showed revenue and EPS beating Wall Street consensus, indicating strong financial performance. The company is also focusing on share repurchase programs, which have become a key mechanism for shareholder returns. AT&T's balance sheet strength, with a lower leverage ratio compared to peers, provides a solid foundation for future growth. These factors make AT&T a top pick in the US telecom space.

BSD Analysis:
AT&T's strategic focus on fiber and 5G positions it well for future growth, especially as it moves away from legacy operations. The company's financials show a strong balance sheet with a healthy cash position and lower debt levels compared to competitors like Verizon and T-Mobile. Despite a lower dividend yield, AT&T's share repurchase strategy enhances total shareholder yield, making it attractive for investors. However, the company must manage its increasing debt levels post-Lumen acquisition and address potential legacy decline risks. Overall, AT&T's balanced mix of wireless and fixed assets, along with its capital return strategy, supports its bullish outlook.

Pitch Summary:
Neurocrine Biosciences has demonstrated strong commercial execution, particularly with its core products Ingrezza and Crenessity, which continue to show robust growth. The company's recent acquisition of Soleno Therapeutics and its drug Vykat XR for Prader-Willi Syndrome presents a potential upside, although there are uncertainties regarding its long-term revenue potential. Neurocrine's financial performance in Q1 2026 was strong, with a 42% increase in revenue and a significant improvement in operating margins. The company has a solid cash position and remains free cash flow positive, which supports its strategic initiatives. Despite some concerns about the pipeline productivity and past over-promising, the market undervalues Neurocrine's core opportunities and risk-adjusted pipeline upside.

BSD Analysis:
Neurocrine's acquisition of Soleno Therapeutics is a strategic move to expand its commercial offerings, but it comes with risks. The efficacy of Vykat XR, while promising, is based on limited data, and there are concerns about side effects such as hyperglycemia and edema. The company's ability to integrate Vykat XR into its portfolio and achieve the projected revenue will be crucial. Neurocrine's management has a track record of effective commercialization, as seen with Ingrezza, which could bode well for Vykat XR's success. However, the acquisition has raised questions about the sustainability of Vykat XR's market exclusivity and its long-term growth potential. Overall, while the acquisition adds complexity to Neurocrine's story, the company's strong existing product lineup and pipeline provide a solid foundation for future growth.

Pitch Summary:
LCI Industries has demonstrated resilience in a challenging market for recreational vehicles, driven by innovation and strategic acquisitions. Despite a decline in RV shipments, the company has increased its revenue and profitability by enhancing the content per RV and expanding into adjacent markets. The firm's recent financial performance exceeded analyst expectations, with significant growth in earnings per share and adjusted profits. Management's focus on innovation, such as new product offerings, has been instrumental in maintaining growth. The stock is considered undervalued compared to peers, presenting a potential upside opportunity.

BSD Analysis:
LCI Industries' strategic focus on innovation and acquisitions has allowed it to navigate a tough market environment effectively. The company's ability to increase the content per RV sold has been a key driver of revenue growth, even as overall industry shipments decline. Its expansion into adjacent markets, such as transportation OEM and marine OEM, further diversifies its revenue streams. Despite potential headwinds, such as weaker than anticipated RV shipments, LCI Industries remains well-positioned due to its competitive pricing and strong product offerings. The recent termination of merger discussions with Patrick Industries could be revisited, providing an additional potential catalyst for the stock.

Pitch Summary:
PayPal Holdings, Inc. has recently experienced a market selloff despite posting solid Q1 earnings, which beat expectations. The company's branded checkout segment, while underperforming, still managed to show slight positive growth. Other segments, such as Venmo, continue to grow robustly. Despite the market's negative reaction, PayPal's valuation appears low, with a P/E ratio of 7-8, suggesting undervaluation compared to its sector and historical averages. The company's strategic initiatives, including a $1.5 billion cost-cutting plan, are expected to improve margins and profitability in the long term.

BSD Analysis:
PayPal's current market challenges are largely due to structural shifts in consumer payment preferences, notably the rise of Apple Pay. However, PayPal's massive user base of 439 million accounts provides a strong foundation for future growth. The company's leadership transition, with Enrique Lores at the helm, brings experience and strategic insight, potentially driving successful adaptation to market changes. PayPal's involvement in the stablecoin space with PYUSD positions it well for future digital currency trends. Overall, while short-term market sentiment is negative, the company's long-term prospects remain promising.

Pitch Summary:
SuperX AI Technology Limited is transitioning from an interior design company to a data center solutions provider, capitalizing on the AI market trend. The company focuses on integrating existing technologies rather than developing proprietary solutions, which raises questions about its value addition. Despite signing partnerships and delivering a proof of concept in Japan, financial disclosures remain limited, and the company's gross profit margins are high but uncertain. The recent buyback strategy has not yielded positive results, as the stock price has fallen. The company's future success hinges on the pilot program's outcome and its ability to secure more substantial mandates.

BSD Analysis:
The company's role as an orchestrator rather than a manufacturer suggests a capital-light model, but this also limits its potential for differentiation and value creation. The pilot project in Japan could lead to significant revenue if successful, potentially expanding to a 300 MW capacity. However, this expansion would require further investment, and the company's current financial position and strategy raise concerns. The Memorandums of Understanding (MoUs) suggest potential business worth $2.1 billion, but these are non-binding and contingent on the pilot's success. Overall, the company's valuation appears high given its cost structure and uncertain margins.

Pitch Summary:
TransMedics Group, Inc. has faced a significant stock price decline following disappointing Q1 2026 earnings, with revenue growth decelerating and financial trends impacted by its venture into owning aircraft. The company's valuation still implies high expectations despite a nearly 40% drop since a previous Sell rating. The organ transplant market appears saturated, and competition within the Organ Care System market is increasing. While international expansion and new product lines like CHOPS offer potential growth, these opportunities seem limited and capital-intensive. The company's ability to sustain high revenue growth and improve free cash flow margins is crucial to justify its current valuation.

BSD Analysis:
TransMedics' business model, which involves selling machines and providing logistics services, results in high costs and limited free cash flow margins. The company's recent entry into the aircraft ownership space has further strained its financials, with macroeconomic factors like rising fuel costs adding pressure. Despite owning a significant share of the Organ Care System market, the company's high valuation multiples are at risk if growth expectations are not met. The potential for TransMedics to become a vertically integrated transplant utility by entering the Organ Procurement Organization space could expand its market, but this depends on uncertain regulatory changes. Until these growth levers materialize, the stock remains overvalued.

Pitch Summary:
Bumble is undergoing a 'quality reset' by reducing its user base to focus on more committed paying users, which has resulted in a 21% drop in paying users but a 9% increase in ARPPU. The company is relaunching its product on a new technology stack, which should enable faster and more efficient updates and improvements. Despite current challenges, Bumble is generating significant cash flow and has improved its EBITDA margins through disciplined marketing spend. The refinancing of its debt has extended maturity to 2030, reducing refinancing risk and allowing for forced deleveraging that benefits equity holders.

BSD Analysis:
Bumble's strategic shift to a new tech stack is crucial for its future growth, as it allows for rapid iteration and testing, addressing past limitations due to technical debt. The company's focus on organic marketing and alternative billing methods, like Apple Pay, is expected to enhance margins further. The upcoming product innovations, including AI-driven features, aim to modernize the user experience without compromising human connection. While the near-term financials may show a dip due to increased investment, the long-term outlook is positive if the company successfully executes its strategy. The management's experience and clear vision for product evolution position Bumble well for future success.

Pitch Summary:
Grown Rogue is poised for significant growth as it increases its production capacity from the current 42% utilization. The company is expanding operations in New Jersey, Illinois, and Minnesota, which will drive future profitability. Despite current market pricing reflecting limited capacity, the potential for increased EBITDA from full utilization presents a substantial investment opportunity. The possibility of interstate commerce further enhances the company's growth prospects, as it can capitalize on higher prices in other states. Grown Rogue's strategic positioning in multiple states offers a strong foundation for future expansion.

BSD Analysis:
Grown Rogue's underutilization presents a unique opportunity for investors, as the market has not yet priced in the company's full earnings potential. The ongoing expansion in key states will significantly boost production and profitability. The company's ability to produce cannabis at competitive costs positions it well for potential interstate commerce, which could unlock higher revenue streams. As Grown Rogue activates additional capacity, it is expected to achieve substantial growth in EBITDA, making it an attractive investment in the cannabis sector. The company's strategic focus on expanding cultivation capacity aligns with broader industry trends and regulatory changes.

Pitch Summary:
LEEF Brands is positioned to capitalize on the growing demand for clean cannabis concentrates. The company has addressed the pesticide contamination issue in California by activating its Salisbury Canyon Ranch, reducing biomass costs significantly. This move has already doubled LEEF's gross margins. With projected EBITDA growth and the potential for interstate commerce, LEEF's valuation could increase substantially. The company is building a platform to produce cannabinoid inputs at unmatched cost, quality, and scale, potentially supplying a significant portion of California's vape market.

BSD Analysis:
LEEF Brands' strategic activation of its Salisbury Canyon Ranch is a game-changer, drastically lowering production costs and improving margins. The company's focus on pesticide-free products addresses a critical issue in the cannabis industry, positioning it as a leader in quality and safety. The potential for interstate commerce and exports could further enhance LEEF's market reach and profitability. As the company scales its production capabilities, it is well-positioned to capture a significant share of the national and international cannabis markets, offering substantial upside potential for investors.